35P Real-world treatment outcomes of amivantamab in pre-approval access (PAA) participants with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations (ex20ins)
Title:
35P Real-world treatment outcomes of amivantamab in pre-approval access (PAA) participants with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations (ex20ins)
Author:
Kim, T.M. Lee, S-H. Chang, G-C. Shih, J-Y. Hochmair, M.J. Sabari, J.K. Spira, A.I. Schioppa, C.A. Rose, J.B. Chioda, M. Panaccione, A. Mahadevia, P. Cho, B.C.